Analyst Articles – US

Regenxbio (NASDAQ:RGNX) Cut to “Sell” at Zacks Investment Research

Zacks Investment Research lowered shares of Regenxbio (NASDAQ:RGNX) from a hold rating to a sell rating in a report issued on Wednesday morning, Zacks.com reports. According to Zacks, “REGENXBIO Inc. is a biotechnology company. The Company focuses on the development, commercialization and licensing of recombinant adeno-associated virus gene therapy. Its products candidates include RGX-501, for […]

Redfin (NASDAQ:RDFN) Lifted to Positive at Susquehanna Bancshares

Susquehanna Bancshares upgraded shares of Redfin (NASDAQ:RDFN) from a neutral rating to a positive rating in a research note issued to investors on Wednesday, BenzingaRatingsTable reports. The firm currently has $23.00 price target on the stock. Several other brokerages have also recently weighed in on RDFN. BidaskClub raised Acceleron Pharma from a strong sell rating […]

Pennantpark Floating Rate Capital (NASDAQ:PFLT) Stock Rating Lowered by Zacks Investment Research

Zacks Investment Research lowered shares of Pennantpark Floating Rate Capital (NASDAQ:PFLT) from a buy rating to a hold rating in a report published on Wednesday, Zacks.com reports. According to Zacks, “PennantPark Floating Rate Capital Ltd. is a business development company. It is a closed-end, externally managed and non-diversified investment company. Its investment objectives are to […]

Nabriva Therapeutics (NASDAQ:NBRV) Downgraded by Zacks Investment Research

Zacks Investment Research downgraded shares of Nabriva Therapeutics (NASDAQ:NBRV) from a buy rating to a hold rating in a research report released on Wednesday morning, Zacks.com reports. According to Zacks, “Nabriva Therapeutics is a biopharmaceutical company engaged in the research and development of new medicines to treat serious bacterial infections, with a focus on the […]

Loop Industries (NASDAQ:LOOP) Upgraded by Zacks Investment Research to Buy

Zacks Investment Research upgraded shares of Loop Industries (NASDAQ:LOOP) from a hold rating to a buy rating in a report released on Wednesday morning, Zacks.com reports. The brokerage currently has $14.00 price objective on the financial services provider’s stock. According to Zacks, “Loop Industries Inc. is a technology company. It created a revolutionary process which […]

IAC/InterActiveCorp (NASDAQ:IAC) Lowered to Hold at Zacks Investment Research

Zacks Investment Research cut shares of IAC/InterActiveCorp (NASDAQ:IAC) from a strong-buy rating to a hold rating in a report released on Wednesday morning, Zacks.com reports. According to Zacks, “IAC is a leading media and Internet company. It is organized into four segments: The Match Group, which consists of dating, education and fitness businesses with brands […]

Kala Pharmaceuticals (NASDAQ:KALA) Downgraded by Zacks Investment Research

Zacks Investment Research lowered shares of Kala Pharmaceuticals (NASDAQ:KALA) from a buy rating to a hold rating in a research note issued to investors on Wednesday morning, Zacks.com reports. According to Zacks, “Kala Pharmaceuticals, Inc. is a biopharmaceutical company. It focused on the development and commercialization of therapeutics through its nanoparticle-based Mucus Penetrating Particles technology. […]

IPG Photonics (NASDAQ:IPGP) Earns Buy Rating from Needham & Company LLC

Needham & Company LLC reissued their buy rating on shares of IPG Photonics (NASDAQ:IPGP) in a research note released on Wednesday, The Fly reports. Needham & Company LLC currently has a $150.00 price target on the semiconductor company’s stock. Other analysts have also issued research reports about the stock. Zacks Investment Research lowered shares of […]

Royal Bank of Canada Raises Cintas (NASDAQ:CTAS) Price Target to $267.00

Cintas (NASDAQ:CTAS) had its price objective raised by Royal Bank of Canada to $267.00 in a research note published on Wednesday, The Fly reports. Royal Bank of Canada currently has an outperform rating on the business services provider’s stock. Several other analysts have also commented on the stock. Credit Suisse Group set a GBX 3,090 […]

BidaskClub Upgrades LKQ (NASDAQ:LKQ) to Hold

BidaskClub upgraded shares of LKQ (NASDAQ:LKQ) from a sell rating to a hold rating in a research note published on Wednesday morning, BidAskClub reports. Other equities research analysts have also recently issued research reports about the stock. Raymond James set a $33.00 price target on shares of LKQ and gave the company a buy rating […]

Insmed (NASDAQ:INSM) Downgraded by BidaskClub

BidaskClub lowered shares of Insmed (NASDAQ:INSM) from a sell rating to a strong sell rating in a research report sent to investors on Wednesday morning, BidAskClub reports. A number of other analysts also recently issued reports on the company. ValuEngine downgraded Zynerba Pharmaceuticals from a buy rating to a hold rating in a research report […]

Northern Trust (NASDAQ:NTRS) Downgraded by BidaskClub

BidaskClub cut shares of Northern Trust (NASDAQ:NTRS) from a hold rating to a sell rating in a research note published on Wednesday morning, BidAskClub reports. A number of other brokerages have also issued reports on NTRS. Wells Fargo & Co reaffirmed a hold rating and set a $11.00 target price on shares of Coty in […]

Gossamer Bio (NASDAQ:GOSS) Downgraded by Zacks Investment Research

Zacks Investment Research downgraded shares of Gossamer Bio (NASDAQ:GOSS) from a buy rating to a hold rating in a report released on Wednesday, Zacks.com reports. According to Zacks, “Gossamer Bio Inc. is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing and commercializing therapeutics in the areas of immunology, inflammation and oncology. The company’s […]

CSX (NASDAQ:CSX) Earns “Market Perform” Rating from Cowen

Cowen reiterated their market perform rating on shares of CSX (NASDAQ:CSX) in a report published on Wednesday morning, Briefing.com Automated Import reports. They currently have a $78.00 price objective on the transportation company’s stock, down from their prior price objective of $80.00. CSX has been the topic of a number of other reports. Credit Suisse […]

Coca-Cola Consolidated (NASDAQ:COKE) Downgraded to Sell at BidaskClub

BidaskClub cut shares of Coca-Cola Consolidated (NASDAQ:COKE) from a hold rating to a sell rating in a research report released on Wednesday morning, BidAskClub reports. NASDAQ:COKE opened at $291.27 on Wednesday. The firm has a market capitalization of $2.73 billion, a price-to-earnings ratio of 47.71 and a beta of 0.80. Coca-Cola Consolidated has a 1-year […]

Park Hotels & Resorts (NYSE:PK) Cut to Sell at Zacks Investment Research

Zacks Investment Research lowered shares of Park Hotels & Resorts (NYSE:PK) from a hold rating to a sell rating in a research report released on Wednesday, Zacks.com reports. According to Zacks, “Park Hotels & Resorts Inc. is a lodging Real Estate Company. The company operates luxury hotels and resorts in USA and international market. Park […]

DA Davidson Boosts Commerce Bancshares (NASDAQ:CBSH) Price Target to $62.00

Commerce Bancshares (NASDAQ:CBSH) had its target price hoisted by DA Davidson to $62.00 in a research note released on Wednesday morning, The Fly reports. The brokerage currently has a neutral rating on the financial services provider’s stock. Several other research analysts have also recently weighed in on the stock. Zacks Investment Research raised shares of […]

Osisko gold royalties (NYSE:OR) Upgraded at Zacks Investment Research

Zacks Investment Research upgraded shares of Osisko gold royalties (NYSE:OR) from a sell rating to a hold rating in a report issued on Wednesday, Zacks.com reports. According to Zacks, “Osisko Gold Ltd is a mining company which is engaged in exploration and mining for gold and other precious metals. Osisko Gold Ltd is headquartered in […]

Farmers National Banc (NASDAQ:FMNB) Downgraded by ValuEngine

ValuEngine downgraded shares of Farmers National Banc (NASDAQ:FMNB) from a hold rating to a sell rating in a research note issued to investors on Wednesday, ValuEngine reports. A number of other brokerages also recently weighed in on FMNB. Raymond James started coverage on shares of PennantPark Investment in a report on Monday, April 29th. They […]

Eiger Biopharmaceuticals (NASDAQ:EIGR) Raised to Buy at Zacks Investment Research

Zacks Investment Research upgraded shares of Eiger Biopharmaceuticals (NASDAQ:EIGR) from a hold rating to a buy rating in a research note published on Tuesday morning, Zacks.com reports. The brokerage currently has $12.00 target price on the biotechnology company’s stock. According to Zacks, “Eiger BioPharmaceuticals, Inc. is a biopharmaceutical company which develops and manufactures drugs and […]

Zacks Investment Research Lowers DiaMedica Therapeutics (NASDAQ:DMAC) to Hold

Zacks Investment Research cut shares of DiaMedica Therapeutics (NASDAQ:DMAC) from a buy rating to a hold rating in a research report released on Tuesday morning, Zacks.com reports. According to Zacks, “DiaMedica Therapeutics Inc. is a biopharmaceutical company. It engages in the development of novel recombinant proteins and monoclonal antibodies. The companys lead product principally consists […]

Gladstone Investment (NASDAQ:GAIN) Rating Lowered to Hold at Zacks Investment Research

Zacks Investment Research cut shares of Gladstone Investment (NASDAQ:GAIN) from a buy rating to a hold rating in a research report released on Tuesday morning, Zacks.com reports. According to Zacks, “Gladstone Investment Corporation is an investment company that seeks to make equity-type investments in small and mid-sized private businesses in the U.S. “ A number […]

Crocs (NASDAQ:CROX) Lifted to Buy at Zacks Investment Research

Zacks Investment Research upgraded shares of Crocs (NASDAQ:CROX) from a hold rating to a buy rating in a research report sent to investors on Tuesday, Zacks.com reports. They currently have $25.00 price objective on the textile maker’s stock. According to Zacks, “Crocs, Inc. is a world leader in innovative casual footwear for men, women and […]

Cellectis (NASDAQ:CLLS) Cut to “Hold” at Zacks Investment Research

Zacks Investment Research downgraded shares of Cellectis (NASDAQ:CLLS) from a buy rating to a hold rating in a report issued on Tuesday, Zacks.com reports. According to Zacks, “Cellectis SA is a gene-editing company. The company focused on developing immunotherapies based on gene edited engineered CAR-T cells. Cellectis SA is based in Paris, France. “ CLLS […]

BRAINSWAY LTD/S (NASDAQ:BWAY) Stock Rating Lowered by Zacks Investment Research

Zacks Investment Research downgraded shares of BRAINSWAY LTD/S (NASDAQ:BWAY) from a buy rating to a hold rating in a research note issued to investors on Tuesday morning, Zacks.com reports. According to Zacks, “BrainsWay Ltd. is a commercial stage medical device company. It is focused on the development and sale of non-invasive neuromodulation products using the […]

Barclays Increases Mercadolibre (NASDAQ:MELI) Price Target to $730.00

Mercadolibre (NASDAQ:MELI) had its price objective raised by Barclays from $615.00 to $730.00 in a report published on Tuesday morning, The Fly reports. Barclays currently has an overweight rating on the stock. MELI has been the subject of a number of other research reports. JPMorgan Chase & Co. set a €54.00 ($62.79) target price on […]

Smart Sand (NASDAQ:SND) Upgraded at B. Riley

B. Riley upgraded shares of Smart Sand (NASDAQ:SND) from a neutral rating to a buy rating in a research report report published on Wednesday morning, Briefing.com Automated Import reports. They currently have $5.00 price target on the stock, up from their previous price target of $4.50. B. Riley also issued estimates for Smart Sand’s Q3 […]

SunTrust Banks Reaffirms “Hold” Rating for eBay (NASDAQ:EBAY)

SunTrust Banks reiterated their hold rating on shares of eBay (NASDAQ:EBAY) in a research report sent to investors on Tuesday morning, AnalystRatings.com reports. The brokerage currently has a $36.00 target price on the e-commerce company’s stock. “We maintain Hold/$36 PT ($40 SOTP) going into 2Q19 earnings due out Wed. 7/17. We expect the results/FY19 outlook […]

Sorrento Therapeutics (NASDAQ:SRNE) Raised to Hold at Zacks Investment Research

Zacks Investment Research upgraded shares of Sorrento Therapeutics (NASDAQ:SRNE) from a sell rating to a hold rating in a research note published on Wednesday morning, Zacks.com reports. According to Zacks, “Sorrento Therapeutics, Inc. is a biopharmaceutical company. It is focused primarily on the acquisition, discovery, development and commercialization of proprietary oncology therapeutics. The Company researches […]

Zacks Investment Research Lowers Lannett (NYSE:LCI) to Hold

Zacks Investment Research downgraded shares of Lannett (NYSE:LCI) from a buy rating to a hold rating in a research report released on Wednesday, Zacks.com reports. According to Zacks, “Lannett Company manufactures and distributes high quality affordable generic medications that are the therapeutic equivalent of the brand-name pharmaceuticals. Their portfolio consists of numerous products across a […]

Synaptics (NASDAQ:SYNA) Lifted to Sell at BidaskClub

BidaskClub upgraded shares of Synaptics (NASDAQ:SYNA) from a strong sell rating to a sell rating in a report released on Wednesday morning, BidAskClub reports. Other equities research analysts also recently issued reports about the company. BMO Capital Markets boosted their target price on Sun Life Financial from C$58.00 to C$60.00 in a research report on […]

Santander Consumer USA (NYSE:SC) Earns “Neutral” Rating from Janney Montgomery Scott

Janney Montgomery Scott reiterated their neutral rating on shares of Santander Consumer USA (NYSE:SC) in a report published on Wednesday, BenzingaRatingsTable reports. A number of other equities research analysts also recently issued reports on SC. Piper Jaffray Companies set a $15.00 price target on shares of BioCryst Pharmaceuticals and gave the company a buy rating […]

Barclays Reiterates “Sell” Rating for Summit Midstream Partners (NYSE:SMLP)

Summit Midstream Partners (NYSE:SMLP)‘s stock had its “sell” rating reiterated by equities researchers at Barclays in a research note issued on Thursday, AnalystRatings.com reports. They currently have a $6.00 target price on the pipeline company’s stock. Barclays‘s price objective would indicate a potential downside of 18.48% from the company’s previous close. A number of other […]

Silicon Motion Technology (NASDAQ:SIMO) Downgraded by BidaskClub

BidaskClub lowered shares of Silicon Motion Technology (NASDAQ:SIMO) from a buy rating to a hold rating in a research note issued to investors on Wednesday morning, BidAskClub reports. Other research analysts have also recently issued reports about the company. Morgan Stanley cut Silicon Motion Technology from an equal weight rating to an underweight rating in […]

Sanmina (NASDAQ:SANM) Upgraded at Zacks Investment Research

Zacks Investment Research upgraded shares of Sanmina (NASDAQ:SANM) from a hold rating to a buy rating in a research report report published on Wednesday, Zacks.com reports. They currently have $33.00 price target on the electronics maker’s stock. According to Zacks, “Sanmina Corporation is engaged in providing electronics contract manufacturing services. It focuses on engineering and […]

Deutsche Bank Initiates Coverage on Sutro Biopharma (NASDAQ:STRO)

Equities researchers at Deutsche Bank initiated coverage on shares of Sutro Biopharma (NASDAQ:STRO) in a note issued to investors on Thursday, MarketBeat.com reports. The firm set a “buy” rating and a $22.00 price target on the stock. Deutsche Bank’s price objective suggests a potential upside of 97.13% from the company’s previous close. A number of […]

Takeda Pharmaceutical (NYSE:TAK) Raised to Buy at Zacks Investment Research

Zacks Investment Research upgraded shares of Takeda Pharmaceutical (NYSE:TAK) from a hold rating to a buy rating in a research report released on Wednesday morning, Zacks.com reports. They currently have $20.00 price objective on the stock. According to Zacks, “Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting […]

New Residential Investment (NYSE:NRZ) Rating Increased to Hold at Zacks Investment Research

New Residential Investment (NYSE:NRZ) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Thursday, Zacks.com reports. According to Zacks, “New Residential Investment Corp. is a real estate investment trust. It focuses on investing in, and actively managing, investments related to residential real estate. The […]

Zacks Investment Research Lowers Criteo (NASDAQ:CRTO) to Hold

Zacks Investment Research downgraded shares of Criteo (NASDAQ:CRTO) from a buy rating to a hold rating in a research note published on Wednesday morning, Zacks.com reports. According to Zacks, “Criteo SA is a global technology company that specializes in performance display advertising. The Company offers clients a range of solutions such as click per cost, […]

Exelixis (NASDAQ:EXEL) Upgraded at ValuEngine

ValuEngine upgraded shares of Exelixis (NASDAQ:EXEL) from a sell rating to a hold rating in a research note issued to investors on Wednesday, ValuEngine reports. Several other research firms have also issued reports on EXEL. Oppenheimer set a $13.00 price target on shares of Alpine Immune Sciences and gave the stock a buy rating in […]